CNBC Business

Lululemon raised its full year guidance and saw its sales and profit rise 18% during its most recent quarter, fueled by a 61% boost in China.

Taylor Swift will have Oct. 13 all to herself, after all, after Universal moved the release date of "The Exorcist: Believer."

Media mogul Barry Diller called on Hollywood studios to make deals and end the writers and actors' strikes.

If marijuana is downgraded to a Schedule III drug, it could be a huge boost to a struggling industry.

Wall Street analysts expect Ozempic to be selected for price negotiations in 2025 due to the amount of money Medicare Part D already spends on the drug.

Polestar is still on track to build 60,000 to 70,000 EVs in 2023, with two new models coming in the next several months.

That move could potentially expand the market for cannabis, sending shares of Canopy Growth, Tilray Brands and Cronos Group higher.

More restaurants and retailers including Starbucks, Dunkin' Donuts and IHOP are launching their limited-time pumpkin items in August.

Fast-fashion retailer Shein is facing more scrutiny from elected officials who want the company to independently prove it doesn't use forced labor.

Many of the drugs are already facing strong competition from other branded medications or patent expirations that will open the market to generic alternatives. 

Warner Bros. Discovery has appointed Mark Thompson chairman and CEO of CNN a few short months after Chris Licht's ouster.

The company saw some growth across its ready-to-drink and tequila categories, but whiskey sales lagged.

The gun industry is finding its footing after a post-pandemic sales slump forced some of the largest manufacturers to roll back production.

While other toy companies have been hammered by a slump in toy demand this year, Lego is one of the few to post positive gains.

The Biden administration unveiled the much-awaited list Tuesday, officially kicking off a process that aims to control rising drug costs in the U.S.

The Plank-Ruhle relationship included private jet rides and access to confidential company information, according to court filings.

"Oppenheimer" continues to explode at the box office. It's Christopher Nolan's third-highest grossing domestic release ever.

The announcement of the 10 drugs kicks off a Medicare negotiation process that aims to make costly medications more affordable for older Americans. 

3M is also awaiting approval of its $10.3 billion settlement over so-called forever chemicals.

All American banks with at least $100 billion in assets would be subject to the new requirement.